Avidity Partners Management »

Cerevel Therapeutics Hldng I shares owned by Avidity Partners Management

Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by Avidity Partners Management from 13F filings

Historical chart of Avidity Partners Management investment in Cerevel Therapeutics Hldng I

Tip: Access up to 7 years of quarterly data

All positions including Cerevel Therapeutics Hldng I held by Avidity Partners Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cerevel Therapeutics Hldng I by Avidity Partners Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $12M 277k 42.40
2023-09-30 $14M 643k 21.83
2023-06-30 $16M 501k 31.79

More positions owned by Avidity Partners Management

Arvinas Ord (ARVN)
Boston Scientific Corporation (BSX)
Cigna Corp Call Option (CI)
Thermo Fisher Scientific (TMO)
Acadia Healthcare (ACHC)
Neurocrine Biosciences (NBIX)
Syndax Pharmaceuticals (SNDX)
Natera (NTRA)
Structure Therapeutics Sponsored Ads (GPCR)
Danaher Corporation (DHR)
Tenet Healthcare Corp Com New (THC)
Karuna Therapeutics Ord
Fusion Pharmaceuticals (FUSN)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Regeneron Pharmaceuticals (REGN)

View all positions for Avidity Partners Management

Top funds holding Cerevel Therapeutics Hldng I

Perceptive Advisors
venBio Select Advisor
Vanguard Group
Paradigm Biocapital Advisors
Balyasny Asset Management
Alpine Associates Management
Baker Bros. Advisors
Alliancebernstein
Millennium Management
Pentwater Capital Management
CNH Partners
Westchester Capital Management
Voloridge Investment Management
Westfield Capital Management Company
T. Rowe Price Associates

View all funds holding Cerevel Therapeutics Hldng I